These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 38969706)

  • 1. IRF5 suppresses metastasis through the regulation of tumor-derived extracellular vesicles and pre-metastatic niche formation.
    Roberts BK; Li DI; Somerville C; Matta B; Jha V; Steinke A; Brune Z; Blanc L; Soffer SZ; Barnes BJ
    Sci Rep; 2024 Jul; 14(1):15557. PubMed ID: 38969706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis.
    Bi X; Hameed M; Mirani N; Pimenta EM; Anari J; Barnes BJ
    Breast Cancer Res; 2011; 13(6):R111. PubMed ID: 22053985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cargo-eliminated osteosarcoma-derived small extracellular vesicles mediating competitive cellular uptake for inhibiting pulmonary metastasis of osteosarcoma.
    Lin S; Shu L; Guo Y; Yuan J; Zhang J; Wang Y; Yang Y; Yuan T
    J Nanobiotechnology; 2024 Jun; 22(1):360. PubMed ID: 38907233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicles of carcinoma-associated fibroblasts creates a pre-metastatic niche in the lung through activating fibroblasts.
    Kong J; Tian H; Zhang F; Zhang Z; Li J; Liu X; Li X; Liu J; Li X; Jin D; Yang X; Sun B; Guo T; Luo Y; Lu Y; Lin B; Liu T
    Mol Cancer; 2019 Dec; 18(1):175. PubMed ID: 31796058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5(+) B- and T-cell trafficking to tumor-conditioned media.
    Pimenta EM; De S; Weiss R; Feng D; Hall K; Kilic S; Bhanot G; Ganesan S; Ran S; Barnes BJ
    Immunol Cell Biol; 2015; 93(5):486-99. PubMed ID: 25533286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conserved region within interferon regulatory factor 5 controls breast cancer cell migration through a cytoplasmic and transcription-independent mechanism.
    Pimenta EM; Barnes BJ
    Mol Cancer; 2015 Feb; 14(1):32. PubMed ID: 25649192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TET2-dependent IL-6 induction mediated by the tumor microenvironment promotes tumor metastasis in osteosarcoma.
    Itoh H; Kadomatsu T; Tanoue H; Yugami M; Miyata K; Endo M; Morinaga J; Kobayashi E; Miyamoto T; Kurahashi R; Terada K; Mizuta H; Oike Y
    Oncogene; 2018 May; 37(22):2903-2920. PubMed ID: 29515232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicles secreted by highly metastatic clonal variants of osteosarcoma preferentially localize to the lungs and induce metastatic behaviour in poorly metastatic clones.
    Macklin R; Wang H; Loo D; Martin S; Cumming A; Cai N; Lane R; Ponce NS; Topkas E; Inder K; Saunders NA; Endo-Munoz L
    Oncotarget; 2016 Jul; 7(28):43570-43587. PubMed ID: 27259278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of pre-metastatic niches induced by tumor extracellular vesicles in lung metastasis.
    Liu Y; Mao D; Wang H; Che X; Chen Y
    Pharmacol Res; 2023 Feb; 188():106669. PubMed ID: 36681367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-derived Cav-1 promotes pre-metastatic niche formation and lung metastasis in breast cancer.
    Wang Y; Li Y; Zhong J; Li M; Zhou Y; Lin Q; Zong S; Luo W; Wang J; Wang K; Wang J; Xiong L
    Theranostics; 2023; 13(5):1684-1697. PubMed ID: 37056561
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor cell-released LC3-positive EVs promote lung metastasis of breast cancer through enhancing premetastatic niche formation.
    Sun X; Wang X; Yan C; Zheng S; Gao R; Huang F; Wei Y; Wen Z; Chen Y; Zhou X; Liu X; Chen B; Shen Y; Cai Y; Pan N; Wang L
    Cancer Sci; 2022 Oct; 113(10):3405-3416. PubMed ID: 35879596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROS-responsive core-shell nano-inhibitor impedes pyruvate metabolism for reinforced photodynamic therapy and interrupted pre-metastatic niche formation.
    Lv M; Zhao B; Zhang J; Miao G; Wei S; Tang Y; Liu X; Qian H; Huang D; Chen W; Zhong Y
    Acta Biomater; 2024 Jul; 182():288-300. PubMed ID: 38729547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-derived extracellular vesicles: The metastatic organotropism drivers.
    Rezaie J; Ahmadi M; Ravanbakhsh R; Mojarad B; Mahbubfam S; Shaban SA; Shadi K; Berenjabad NJ; Etemadi T
    Life Sci; 2022 Jan; 289():120216. PubMed ID: 34890589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Role of Osteosarcoma-Derived Extracellular Vesicles in Pre-Metastatic Niche Formation and Metastasis in the 143-B Xenograft Mouse Osteosarcoma Model.
    Mazumdar A; Urdinez J; Boro A; Arlt MJE; Egli FE; Niederöst B; Jaeger PK; Moschini G; Muff R; Fuchs B; Snedeker JG; Gvozdenovic A
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33233625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The temporal progression of lung immune remodeling during breast cancer metastasis.
    McGinnis CS; Miao Z; Superville D; Yao W; Goga A; Reticker-Flynn NE; Winkler J; Satpathy AT
    Cancer Cell; 2024 Jun; 42(6):1018-1031.e6. PubMed ID: 38821060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Cell-derived Secretory Factors in Breast Cancer-associated Lung Metastasis: Their Mechanism and Future Prospects.
    Urooj T; Wasim B; Mushtaq S; Shah SNN; Shah M
    Curr Cancer Drug Targets; 2020; 20(3):168-186. PubMed ID: 31858911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Vesicle-Mediated Purinergic Signaling Contributes to Host Microenvironment Plasticity and Metastasis in Triple Negative Breast Cancer.
    Duan S; Nordmeier S; Byrnes AE; Buxton ILO
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteosarcoma-Derived Extracellular Vesicles Induce Lung Fibroblast Reprogramming.
    Mazumdar A; Urdinez J; Boro A; Migliavacca J; Arlt MJE; Muff R; Fuchs B; Snedeker JG; Gvozdenovic A
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis.
    Wong CC; Zhang H; Gilkes DM; Chen J; Wei H; Chaturvedi P; Hubbi ME; Semenza GL
    J Mol Med (Berl); 2012 Jul; 90(7):803-15. PubMed ID: 22231744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases.
    Chute C; Yang X; Meyer K; Yang N; O'Neil K; Kasza I; Eliceiri K; Alexander C; Friedl A
    Breast Cancer Res; 2018 Jul; 20(1):66. PubMed ID: 29976229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.